QuickView for NECTIN4;jsessionid=E63284A1E28859AA2C2850166D9E2039 (gene)

1. Scratching the Surface: NECTIN-4 as a Surrogate for Enfortumab Vedotin Resistance.
2. Expression of PVRL4, a molecular target for cancer treatment, is transcriptionally regulated by FOS.
3. Nectin-4 has emerged as a compelling target for breast cancer.
4. NECTIN-4 targeted theranostics for urothelial cancer: getting ready for primetime?
5. Nectin-4: a Tumor Cell Target and Status of Inhibitor Development.

There were no clinical trials for NECTIN4;jsessionid=E63284A1E28859AA2C2850166D9E2039